Efficacy and safety analysis of induction therapy for unresectable locally advanced non-small-cell lung cancer: a retrospective study based on IPTW

Tianlong Chen, Hongxu Zhang, Hongtao Yin, Mingyan Li, Qian Zhang, Jiaao Liu, Hao Qi · 2026

Read Efficacy and safety analysis of induction therapy for unresectable locally advanced non-small-cell lung cancer: a retrospective study based on IPTW by Tianlong Chen, Hongxu Zhang, Hongtao Yin, Mingyan Li, Qian Zhang, Jiaao Liu, Hao Qi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13619472.txt.

Description

Tianlong Chen and co-authors test front-loading immune chemotherapy before radiation for hard lung cancer. Their 2026 study deals with locally advanced non-small-cell lung cancer that surgery can not take, where chemoradiation plus immune upkeep is standard yet many still progress. Records from one cancer hospital split patients into those who got induction chemoimmunotherapy first and those who went straight to chemoradiation. A weighting method balanced the groups.

After weighting, the front-loaded group lived markedly longer and stayed progression-free longer. Side effects matched overall, save more thyroid overactivity in the front-loaded arm. The authors call for trials to confirm the gain.

Catalog record

CREATORTianlong Chen, Hongxu Zhang, Hongtao Yin, Mingyan Li, Qian Zhang, Jiaao Liu, Hao Qi
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE30 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13619472

Browse the full library · About the Tower of Babel